Conatus Pharmaceuticals Market Cap 2012-2018 | CNAT
Conatus Pharmaceuticals market cap history and chart from 2012 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Conatus Pharmaceuticals market cap as of March 22, 2019 is $0.04B.
||Medical Products Manufacturing
Conatus Pharmaceuticals, Inc. is a biotechnology company. It is focused on developing and commercializing medicines to treat liver disease. The Company is developing its lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. Conatus Pharmaceuticals, Inc. is headquartered in San Diego, California.